Abstract
Among the functional gastrointestinal disorders, functional disorders of the esophagus are second in prevalence only to irritable bowel syndrome. Progress has been made in recent years in our understanding of the pathophysiology of functional esophageal disorders. In this review we focus on recent advances in their diagnosis and treatment. Additionally, we critically appraise the current understanding of the various clinical aspects of each esophageal disorder. Finally, we highlight unanswered questions and areas of controversy.
Similar content being viewed by others
References and Recommended Reading
Drossman DA, Li Z, Andruzzi E, et al.: U.S. householder survey of functional gastrointestinal disorders: prevalence, sociodemography, and health impact. Dig Dis Sci 1993, 38:1569–1580.
Thompson WG, Irvine EJ, Pare P, et al.: Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 2002, 47:225–235.
Rome II: The Functional Gastrointestinal Disorders. Lawrence, KS: Allen Press; 2000.
Akehurst RL, Brazier JE, Mathers N, et al.: Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting. Pharmacoeconomics 2002, 20:455–462.
Koloski NA, Talley NJ, Boyce PM: The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol 2000, 95:67–71.
Badia X, Mearin F, Balboa A, et al.: Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. Pharmacoeconomics 2002, 20:749–758.
El-Serag HB, Olden K, Bjorkman D: Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 2002, 16:1171–1185.
Lindgren S, Janzon L: Prevalence of swallowing complaints and clinical findings among 50-79-year-old men and women in an urban population. Dysphagia 1991, 6:187–192.
Colon VJ, Young MA, Ramirez FC. The short- and long-term efficacy of empirical esophageal dilation in patients with nonobstructive dysphagia: a prospective, randomized study. Am J Gastroenterol 2000, 95:910–913.
Langdon DE: Dysphagia and Maloney dilations. Am J Gastroenterol 2001, 96:3045–3046.
Scolapio JS, Gostout CJ, Schroeder KW, et al.: Dysphagia without endoscopically evident disease: to dilate or not? Am J Gastroenterol 2001, 96:327–330. This is the first study to assess the value of empiric esophageal dilation in functional dysphagia, compared with a sham procedure.
Dent J, Brun J, Fendrick AM, et al.: An evidence-based appraisal of reflux disease management: The Genval Workshop Report. Gut 1999, 44(Suppl 2):S1-S16.
Fass R, Fennerty MB, Vakil N: Nonerosive reflux disease: current concepts and dilemmas. Am J Gastroenterol 2001, 96:303–314.
Martinez SD, Malagon IB, Garewal HS, et al.: Non-erosive reflux disease (NERD): acid reflux and symptom patterns. Aliment Pharmacol Ther 2003, 17:537–545.
Trimble KS, Pryde A, Heading RC: Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD. Gut 1995, 37:7–12.
Fass R, Tougas G: Functional heartburn: the stimulus, the pain and the brain. Gut 2002, 51:885–892. An excellent up-to-date review of the topic.
Schindlbeck NE, Wiebecke B, Klauser AG, et al.: Diagnostic value of histology in non-erosive gastro-oesophageal reflux disease. Gut 1996, 39:151–154.
Pandolfino JE, Kahrilas PJ, Cisler J, et al.: Esophageal pH monitoring using a catheter-free pH-system (Bravo pH System) [abstract 152]. Gastroenterology 2002, 122:A-192.
Lind T, Havelund T, Carlsson R, et al.: Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997, 32:974–979.
Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, et al.: Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol 1997, 92:1997–2000.
Fass R, Ofman JJ, Gralnek IM, et al.: Clinical and economic assessment of omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med 1999, 159:2161–2168.
Watson RG, Tham TC, Johnston BT, McDougall NI: Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms. Gut 1997, 40:587–590.
Pehlivanov N, Liu J, Mittal RK: Sustained esophageal contraction: a motor correlate of heartburn symptom. Am J Physiol Gastrointest Liver Physiol 2001, 281:G743-G751.
Tack J, Janssens J: Functional heartburn. Curr Treat Options Gastroenterol 2002, 5:251–258.
Clouse RE, Lustman PJ, Eckert TC, et al.: Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities: a double-blind, placebo-controlled trial. Gastroenterology 1987, 92:1027–1036.
Cannon RO III, Quyyumi AA, Mincemoyer R, et al.: Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 1994, 330:1411–1417.
Moloy PJ, Charter R: The globus symptom: incidence, therapeutic response, and age and sex relationships. Arch Otolaryngol 1982, 108:740–744.
Shiomi Y, Shiomi Y, Oda N, Hosoda S: Hyperviscoelasticity of epipharyngeal mucus may induce globus pharyngis. Ann Otol Rhinol Laryngol 2002, 111:1116–1119.
Marshall JN, McGann G, Cook JA, Taub N: A prospective controlled study of high-resolution thyroid ultrasound in patients with globus pharyngeus. Clin Otolaryngol 1996, 21:228–231.
Book DT, Rhee JS, Toohill RJ, Smith TL: Perspectives in laryngopharyngeal reflux: an international survey. Laryngoscope 2002, 112:1399–1406.
Tokashiki R, Yamaguchi H, Nakamura K, Suzuki M: Globus sensation caused by gastro esophageal reflux disease. Auris Nasus Larynx 2002, 29:347–351.
Watson WC, Sullivan SN: Hypertonicity of the cricopharyngeal sphincter: a cause of globus sensation. Lancet 1974, 2:1417–1419.
Caldarelli DD, Andrews AH Jr, Derbyshire AJ: Esophageal motility studies in globus sensation. Ann Otol Rhinol Laryngol 1970, 79:1098–1100.
Cook IJ, Dent J, Collins SM: Upper esophageal sphincter tone and reactivity to stress in patients with a history of globus sensation. Dig Dis Sci 1989, 34:672–676.
Corso MJ, Pursnani KG, Mohiuddin MA, et al.: Globus sensation is associated with hypertensive upper esophageal sphincter but not with gastroesophageal reflux. Dig Dis Sci 1998, 43:1513–1517.
Sun J, Xu B, Yuan YZ, Xu JY: Study on the function of pharynx and upper esophageal sphincter in globus hystericus. World J Gastroenterol 2002, 8:952–955.
Moser G, Wenzel-Abatzi TA, Stelzneder M, et al.: Globus sensation: pharyngoesophageal function, psychometric and psychiatric findings, and follow-up in 88 patients. Arch Intern Med 1998, 158:1365–1373.
TroshinskyMB, Castell DO. Achalasia. In Esophageal Motility Testing, edn 2. Edited by Castell DO, Castell JA. Norwalk, CT: Appleton & Lange; 1994:109–121.
Amarnath RP, Abell TL, Malagelada JR: The rumination syndrome in adults: a characteristic manometric pattern. Ann Intern Med 1986, 105:513–518.
O’Brien MD, Bruce BK, Camilleri M: The rumination syndrome: clinical features rather than manometric diagnosis. Gastroenterology 1995, 108:1024–1029.
Thumshirn M, Camilleri M, Hanson RB, et al.: Gastric mechanosensory and lower esophageal sphincter function in rumination syndrome. Am J Physiol 1998, 275:G312-G321.
Oelschlager BK, Chan MM, Eubanks TR, et al.: Effective treatment of rumination with Nissen fundoplication. J Gastrointest Surg 2002, 6:638–644.
Locke GR III, Talley NJ, Fett SL, et al.: Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997, 112:1448–1456.
FassR, Malagon I, Schmulson M: Chest pain of esophageal origin. Curr Opin Gastroenterol 2001, 17:376–380. This article reviews all major developments in the pathophysiology, diagnosis, and treatment of patients with chest pain of esophageal origin.
Martinez SD, Malagon I, Garewal HS, Fass R: The usefulness of symptom index (SI) in improving diagnosis of gastroesophageal reflux disease (GERD) related noncardiac chest pain (NCCP) [abstract 3196]. Gastroenterology 2001, 120(Suppl 1):A-630.
Katz PO, Dalton CB, Richter JE, et al.: Esophageal testing of patients with noncardiac chest pain or dysphagia. Ann Intern Med 1987, 106:593–597.
Fass R, Pearson T, De Garmo P, Fennerty MB: Esophageal motor function assessment of patients with dysphagia and chest pain. The Clinical Outcomes Research (CORI) experience [abstract A-188]. Gastroenterology 2002, 122(Suppl 1):S1234.
Richter JE, Dalton CB, Bradley LA, Castell DO: Oral nifedipine in the treatment of noncardiac chest pain in patients with the nutcracker esophagus. Gastroenterology 1987, 93:21–28.
Cattau EL, Jr, Castell DO, Johnson DA, et al.: Diltiazem therapy for symptoms associated with nutcracker esophagus. Am J Gastroenterol 1991, 86:272–276.
Miller LS, Pullela SV, Parkman HP, et al.: Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal. Am J Gastroenterol 2002, 97:1640–1646.
Prakash C, Clouse RE: Long-term outcome from tricyclic antidepressant treatment of functional chest pain. Dig Dis Sci 1999, 44:2373–2379.
Gorelick AB, Koshy SS, Hooper FG, et al.: Differential effects of amitriptyline on perceptions of somatic and visceral stimulation in healthy humans. Am J Physiol 1998, 275:G460-G466.
Peghini PL, Katz PO, Castell DO: Imipramine decreases oesophageal pain perception in human male volunteers. Gut 1998, 42:807–813.
Varia I, Logue E, O’Connor C, et al.: Randomized trial of sertraline in patients with explained chest pain of noncardiac origin. Am Heart J 2000, 140:367–372. One of the first studies that evaluated the efficacy of sertraline, a selective serotonin reuptake inhibitor, on symptoms of patients with noncardiac chest pain.
Wulsin LR, Maddock R, Beitman B, et al.: Clonazepam treatment of panic disorder in patients with recurrent chest pain and normal coronary arteries. Int J Psychiatry Med 1999, 29:97–105.
Beitman BD, Basha IM, Trombka LH, et al.: Pharmacotherapeutic treatment of panic disorder in patients presenting with chest pain. J Fam Pract 1989, 28:177–180.
Rao SS, Mudipalli RS, Mujica V, et al.: An open-label trial of theophylline for functional chest pain. Dig Dis Sci 2002, 47:2763–2768.
Klimes I, Mayou RA, Pearce MJ, et al.: Psychological treatment for typical non-cardiac chest pain: a controlled evaluation. Psychol Med 1990, 20:605–611.
Hegel MT, Abel GG, Etscheidt M, et al.: Behavioral treatment of angina-like chest pain in patients with hyperventilation syndrome. J Behav Ther Exp Psychiatry 1989, 20:31–39.
Cunningham C, Brown S, Kaski JC: Effects of transcendental meditation on symptoms and electrocardiographic changes in patients with cardiac syndrome X. Am J Cardiol 2000, 85:653–655.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dekel, R., Fass, R. Current perspectives on the diagnosis and treatment of functional esophageal disorders. Curr Gastroenterol Rep 5, 314–322 (2003). https://doi.org/10.1007/s11894-003-0069-8
Issue Date:
DOI: https://doi.org/10.1007/s11894-003-0069-8